Stay updated with breaking news from Sandra Demaria. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two types of immunotherapy-;one that boosts T cells, and another that boosts dendritic cells-;can control tumors in preclinical models of triple negative breast cancer, a cancer type that's typically resistant to immunotherapy alone.
Researchers are looking for ways to enhance the antitumor response. Now, researchers at Weill Cornell Medicine and Albert Einstein College of Medicine, report they have discovered tumors can use an enzyme called ART1 to thwart antitumor immune cells.
Tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments, according to a study from researchers at Weill Cornell Medicine and Albert Einstein College of Medicine.
Milwaukee, WI (PRWEB) October 25, 2021 -- The Society for Immunotherapy of Cancer (SITC) has announced its 2021 Annual Awards recipients, recognizing